Pre-clinical studies found that the expression of the Zinc Finger transcription factor ZNF143 was upregulated in NSCLC, both in adenocarcinoma and squamous cell histotype samples, and its increased expression was significantly associated with advanced TNM stages, although survival analysis failed to demonstrate its role as a prognosticator [54]. This evidence concerns the gene ZNF143 and non-small cell lung carcinoma.